Guided Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GTHP research report →
Companywww.guidedinc.com
Guided Therapeutics, Inc. , a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
- CEO
- Mark L. Faupel
- IPO
- 2021
- Employees
- 4
- HQ
- Norcross, GA, US
Price Chart
Valuation
- Market Cap
- $14.02M
- P/E
- -4.13
- P/S
- 18.28
- P/B
- -3.14
- EV/EBITDA
- -5.99
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 67.93%
- Op Margin
- -322.95%
- Net Margin
- -512.65%
- ROE
- 70.53%
- ROIC
- 103.60%
Growth & Income
- Revenue
- $767.00K · 10857.14%
- Net Income
- $-3,196,000 · -32.23%
- EPS
- $-0.04 · 5.53%
- Op Income
- $-2,372,000
- FCF YoY
- 4.38%
Performance & Tape
- 52W High
- $0.54
- 52W Low
- $0.09
- 50D MA
- $0.23
- 200D MA
- $0.28
- Beta
- 0.85
- Avg Volume
- 17.82K
Get TickerSpark's AI analysis on GTHP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 26, 26 | Blumberg Richard P. | other | 352,000 |
| Mar 26, 26 | Blumberg Richard P. | other | 19,038 |
| Mar 26, 26 | Blumberg Richard P. | other | 1,040,000 |
| Mar 26, 26 | Blumberg Richard P. | other | 56,093 |
| Feb 25, 26 | Blumberg Richard P. | other | 1,000,000 |
| Mar 1, 26 | Blumberg Richard P. | other | 900,000 |
| Feb 25, 26 | Blumberg Richard P. | other | 1,000,000 |
| Feb 25, 26 | Blumberg Richard P. | other | 1,000,000 |
| Mar 10, 26 | Blumberg Richard P. | other | 110,000 |
| Feb 25, 26 | Blumberg Richard P. | sell | 1,000,000 |
Our GTHP Coverage
We haven't published any research on GTHP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GTHP Report →